We are live on ! Find out more
COEPW

Coeptis Therapeutics Warrants
COEPW

Delisted

COEPW was delisted on the 24th of April, 2026.

Back to rankings

19 hedge funds and large institutions have $155K invested in Coeptis Therapeutics Warrants in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

6% more funds holding

Funds holding: 18 → 19 (+1)

46% less capital invested

Capital invested by funds: $286K → $155K (-$132K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
19
Holders Change
+1
Holders Change %
+5.56%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Skaana Management
New York
+$3.48K
2
WAM
Wolverine Asset Management
Illinois
+$783

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$14.7K
2
AA
AQR Arbitrage
Connecticut
-$2.08K
3
RCM
Radcliffe Capital Management
Pennsylvania
-$321
4
HF
HRT Financial
New York
-$82
Name Holding Trade Value Shares
Change 		Change in
Stake
ICM
1
Ionic Capital Management
New York
$38.6K – – –
KC
2
Kepos Capital
New York
$19K +$29.8K +250,000 New
CF
3
Cantor Fitzgerald
New York
$12.8K – – –
MC
4
Meteora Capital
Florida
$11.1K – – –
Wells Fargo
5
Wells Fargo
California
$10.9K – – –
RCM
6
Rivernorth Capital Management
Florida
$10.8K – – –
CL
7
CSS LLC
Illinois
$10.6K – – –
Walleye Capital
8
Walleye Capital
New York
$7.82K – – –
HF
9
HRT Financial
New York
$6K -$82 -691 -0.7%
AA
10
AQR Arbitrage
Connecticut
$5.56K -$2.08K -17,437 -18%
RCM
11
Radcliffe Capital Management
Pennsylvania
$5.25K -$321 -2,694 -4%
Walleye Trading
12
Walleye Trading
New York
$5.2K – – –
SIA
13
SkyView Investment Advisors
New Jersey
$4K – – –
LCM
14
Landscape Capital Management
New Jersey
$2.3K – – –
SM
15
Skaana Management
New York
$2.04K +$3.48K +29,180 New
WAM
16
Wolverine Asset Management
Illinois
$1.64K +$783 +6,569 +40%
HHGC
17
Hunting Hill Global Capital
New York
$1.18K – – –
CS
18
Clear Street
New York
$100 – – –
Susquehanna International Group
19
Susquehanna International Group
Pennsylvania
– -$14.7K -100,139 Closed

COEPW Hedge Fund Activity: Q2 2023 in Review

19 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Coeptis Therapeutics Warrants (COEPW) for Q2 2023, worth a combined $155K — down 46% from $286K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new COEPW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.

The largest buyer was Skaana Management, opening a new position worth an estimated $3.48K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $14.7K sold.

  • 19 institutional investors held Coeptis Therapeutics Warrants (COEPW) as of Q2 2023, up from 18 in Q1 2023.
  • Funds reported $155K of Coeptis Therapeutics Warrants stock for Q2 2023, down 46% quarter-over-quarter.
  • 2 funds opened new Coeptis Therapeutics Warrants positions in Q2 2023 and 1 closed out, a net change of +1 holder.
  • The largest Coeptis Therapeutics Warrants buyer in Q2 2023 was Skaana Management, an estimated $3.48K added.
  • The largest Coeptis Therapeutics Warrants seller in Q2 2023 was Susquehanna International Group, an estimated $14.7K sold.

Based on aggregated 13F filings for Q2 2023.